What is the current Price Target for the Apontis Pharma stock?

The average Apontis Pharma target price is €10.00. This is -13.79% lower than the current stock price. 1 Analyst has issued a Apontis Pharma price target 2026.

How high will the Apontis Pharma stock rise?

No reliable answer can be given as to how high the Apontis Pharma stock will rise. The performance of stocks, including the Apontis Pharma stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Apontis Pharma stock today?

The performance of Apontis Pharma stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Apontis Pharma stock fall?

The decline in Apontis Pharma stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Apontis Pharma Forecast, price target & analysts

€11.60

0.43% yesterday

Xetra, May 28, 05:36 pm CET

ISIN

DE000A3CMGM5

Symbol

APPH

Index

Scale

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Apontis Pharma Target price 2025 - Analyst rating & recommendation

Apontis Pharma Classifications & Recommendation:

Sell

100%

Apontis Pharma Price Target

Target Price	€10.00
Price	€11.60
Deviation	13.79% register free of charge
Number of Estimates	1

	1 Analyst has issued a Apontis Pharma price target 2026. The average Apontis Pharma target price is €10.00. This is 13.79% register free of charge lower than the current stock price.
	A rating was issued by 1 analysts: 0 Analysts recommend Apontis Pharma to buy, 0 to hold and 1 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Apontis Pharma stock has an average upside potential 2026 of 13.79% register free of charge . Most analysts recommend the Apontis Pharma stock at Sale.

Current Apontis Pharma Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
WARBURG RESEARCH GMBH	Locked ➜ Locked	Locked	Mar 06 2025
FIRST BERLIN EQUITY RESEARCH	Locked ➜ Locked	Locked	Dec 02 2024
WARBURG RESEARCH GMBH	Locked ➜ Locked	Locked	Nov 06 2024
HAUCK AUFHAEUSER INVESTMENT BANKING	Locked ➜ Locked	Locked	Oct 17 2024

Analyst Rating	Date
Locked WARBURG RESEARCH GMBH: Locked ➜ Locked	Mar 06 2025
Locked FIRST BERLIN EQUITY RESEARCH: Locked ➜ Locked	Dec 02 2024
Locked WARBURG RESEARCH GMBH: Locked ➜ Locked	Nov 06 2024
Locked HAUCK AUFHAEUSER INVESTMENT BANKING: Locked ➜ Locked	Oct 17 2024

Discover more stocks with a high price target

NIO ADR 45.36%

Novo Nordisk 44.44%

BioNTech SE - ADR 38.52%

TUI 37.92%

Alibaba Group Holding Ltd 36.51%

MongoDB 35.28%

Tencent Holdings Ltd. 25.72%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now

The Apple stock at a glance with charts, current key metrics, news and stock analyses.

The Best Dividend Stocks in the Dividend Top Scorer list.

Stock Analyses of the Best Stocks Worldwide.

Start building wealth today